Barriers to oncofertility care among female adolescent cancer patients in Canada
TS Glazer, F Schulte - Current Oncology, 2022 - mdpi.com
High survival rates in adolescent cancer patients have shifted the medical focus to the long-
term outcomes of cancer treatments. Surgery, chemotherapy, and radiation increase the risk …
term outcomes of cancer treatments. Surgery, chemotherapy, and radiation increase the risk …
Protective effects of antioxidants on cyclophosphamide-induced ovarian toxicity
RS Barberino, RLS Silva… - Biopreservation and …, 2023 - liebertpub.com
The most common limitation of anticancer chemotherapy is the injury to normal cells.
Cyclophosphamide, which is one of the most widely used alkylating agents, can cause …
Cyclophosphamide, which is one of the most widely used alkylating agents, can cause …
Integrative analysis of transcriptomic and metabolomic profiles reveals abnormal phosphatidylinositol metabolism in follicles from endometriosis‐associated infertility …
Y Dai, X Lin, N Liu, L Shi, F Zhuo… - The Journal of …, 2023 - Wiley Online Library
Endometriosis is a common gynecological disorder that causes female infertility. Our recent
research found that excessive oxidative stress in ovaries of endometriosis patients induced …
research found that excessive oxidative stress in ovaries of endometriosis patients induced …
[HTML][HTML] Effects of Ganoderma lucidum polysaccharide peptide ameliorating cyclophosphamide-induced immune dysfunctions based on metabolomics analysis
J Xie, D Lin, J Li, T Zhou, S Lin, Z Lin - Frontiers in Nutrition, 2023 - frontiersin.org
Ganoderma lucidum polysaccharide peptide (GLPP), is one of the most constituents of
Ganoderma lucidum (G. lucidum) with a wide range of functional activities. The present …
Ganoderma lucidum (G. lucidum) with a wide range of functional activities. The present …
Cyclophosphamide reduces gene transcriptional activity and embryo in vitro development by inhibiting NF-κB expression through decreasing AcH4K12
ZB Luo, LH Yang, SZ Han, SY Chang, H Liu… - Chemico-Biological …, 2024 - Elsevier
Cyclophosphamide (CTX), a widely used chemotherapeutic agent for cancer treatment, has
been associated with long-term toxicity and detrimental effects on oocytes and ovaries …
been associated with long-term toxicity and detrimental effects on oocytes and ovaries …
The EZH2-H3K27me3 axis modulates aberrant transcription and apoptosis in cyclophosphamide-induced ovarian granulosa cell injury
Y Chen, L Ai, Y Zhang, X Li, S Xu, W Yang, J Jin… - Cell Death …, 2023 - nature.com
Chemotherapy-induced ovarian damage and infertility are significant concerns for women of
childbearing age with cancer; however, the underlying mechanisms are still not fully …
childbearing age with cancer; however, the underlying mechanisms are still not fully …
Current Trends on Bioengineering Approaches for Ovarian Microenvironment Reconstruction
Ovarian tissue has a unique microarchitecture and a complex cellular and molecular
dynamics that are essential for follicular survival and development. Due to this great …
dynamics that are essential for follicular survival and development. Due to this great …
The future of fertility preservation for women treated with chemotherapy
LR Alesi, QN Nguyen, JM Stringer… - Reproduction and …, 2023 - raf.bioscientifica.com
Cytotoxic chemotherapies have been a mainstay of cancer treatment but are associated with
numerous systemic adverse effects, including impacts on fertility and endocrine health …
numerous systemic adverse effects, including impacts on fertility and endocrine health …
Rapamycin prevents cyclophosphamide-induced ovarian follicular loss and potentially inhibits tumour proliferation in a breast cancer xenograft mouse model
Y Tanaka, T Amano, A Nakamura, F Yoshino… - Human …, 2024 - academic.oup.com
STUDY QUESTION To what extent and via what mechanism does the concomitant
administration of rapamycin (a follicle activation pathway inhibitor and antitumour agent) and …
administration of rapamycin (a follicle activation pathway inhibitor and antitumour agent) and …
Unveiling the mechanisms and challenges of cancer drug resistance
Cancer treatment faces many hurdles and resistance is one among them. Anti-cancer
treatment strategies are evolving due to innate and acquired resistance capacity, governed …
treatment strategies are evolving due to innate and acquired resistance capacity, governed …